Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Vivani Medical Inc.
VANICurrent price
1.29 USD
+0.05 USD (+4.03%)
Last closed
1.24 USD
Company
www.vivani.com
ISIN
unknown
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
64 649 400 USD
Yield for 12 month
+38.71 %
1Y
3Y
5Y
10Y
15Y
VANI
Vivani Medical, Inc., a preclinical stage biopharmaceutical company, engages in the development of miniaturized and subdermal implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates in the treatment of chronic disease, medication non-adherence. Its pipeline includes NPM-115, a high-dose exenatide implant candidate is in preclinical stage development for the treatment of chronic weight management in patients with obesity or overweight; NPM-119, an exenatide implant candidate is in preclinical stage development for the treatment of patients with type 2 diabetes; NPM-139, a miniature, subdermal GLP-1 implant in development for chronic weight management; and OKV-119, an exenatide implant is under development for metabolic diseases in cats including for the treatment of obesity and diabetes. The company is headquartered in Alameda, California. Address: 1350 South Loop Road, Alameda, CA, United States, 94502
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
8 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
-357 000 USD
Last Year
-381 000 USD
Current Quarter
-100 000 USD
Last Quarter
-99 000 USD
Key Figures VANI
1 year
3 years
5 years
10 years
EBITDA
-24 901 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-29.29 %
PEG Ratio
–
Return On Equity TTM
-86.1 %
Wall Street Target Price
8 USD
Revenue TTM
–
Book Value
0.43 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
130 000 USD
Earnings per share
-0.46 USD
Diluted Eps TTM
-0.46 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics VANI
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History VANI
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:3
Payout Ratio
–
Last Split Date
19.08.2022
Dividend Date
06.01.2020
Stock Valuation VANI
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
-3.9274
Price Book MRQ
2.7136
Financials VANI
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators VANI
For 52 weeks
0.84 USD
4.8 USD
50 Day MA
1.26 USD
Shares Short Prior Month
940 010
200 Day MA
1.43 USD
Short Ratio
11.57
Shares Short
834 227
Short Percent
2.76 %
BeatStart